Neurocrine Biosciences
NBIX
#1201
Rank
NZ$27.80 B
Marketcap
$274.63
Share price
-0.96%
Change (1 day)
17.47%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company